Key points are not available for this paper at this time.
Magnetic nanoparticle-based hyperthermia has emerged as a promising therapeutic modality for treating malignant solid tumors that exhibit resistance to conventional cancer treatments, including chemotherapy and radiation. Despite the clinical approval of superparamagnetic iron oxide nanoparticles (SPIONs) for the adjunct treatment of recurrent glioblastoma, their therapeutic potential is undercut by chemical synthesis-inherent limitations such as low saturation magnetization, superparamagnetic characteristics, and a wide nanoparticle size distribution. Here, we introduce an micromagnetic modelling-based SAF-MDP design with in-plane magnetization, optimized through specific uniaxial anisotropy adjustments to avert the spin-flop phenomenon and eliminate hysteresis-free hard-axis magnetization loops, paired with a mechanofluidic modeling approach to assess the alignment of the SAF-MDP to the applied alternating magnetic field (AMF). Magnetic Force Microscopy characterization provides unprecedented insights into the particle switching behaviour on a single particle scale. This comprehensive strategy spanning micromagnetics and advanced magnetic characterization enables the design of particles with heating efficiencies to approach the theoretical maximum, dictated by the saturation magnetization of the utilized materials and limited solely by the biologically acceptable frequencies and amplitudes of the oscillating magnetic field. Our work not only addresses the limitations encountered by previous methodologies but also sets the stage for the development of advanced SAF-MDP designs and alignment techniques. This opens a new avenue to hyperthermia-based cancer therapy, delineated only by the boundaries of physical laws and biological safety standards.
Scheibler et al. (Mon,) studied this question.